Competing Gut Bacterial Guilds for Genome-Centric Disease Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current gene-centric approaches for metagenomic data analysis in microbiome-wide association studies (MWAS) fail to account for the ecological interactions of bacterial strains, leading to spurious correlations and overlooking functional guilds that are crucial for understanding disease biomarkers.

Innovation Solution

Employing a genome-centric approach that identifies metagenome-assembled genomes (MAGs) and their guild-level aggregation to analyze gut microbiome features, recognizing guilds as functional units that interact coherently and affect host health, using a Random Forest regression model to correlate guild abundance with disease phenotypes.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If gene-centric approaches are used for metagenomic data analysis, then individual genes can be annotated using existing databases, but ecological interactions between bacterial strains are ignored leading to spurious correlations

Engineering Contradiction:
Improveease of data analysisVSAvoidaccuracy of disease biomarker identification
Core Design Contradiction:
Ease of manufactureVSReliability

Solution Approach 1:

The patent merges multiple genes that belong to the same functional pathway or metabolic module into a single functional unit. This combining approach preserves the ecological relationships between bacterial strains by analyzing genes at the pathway level rather than individual gene level, thereby eliminating spurious correlations while maintaining analytical feasibility through database annotation of consolidated functional units

Inventive Principle:
Principle #5Merging (Combining)

2Productivity

If individual genes are treated as independent units, then database annotation can be performed efficiently, but the ecological behavior of bacterial carriers is disregarded

Engineering Contradiction:
Improvespeed of microbiome analysisVSAvoidloss of ecological interaction information
Core Design Contradiction:
ProductivityVSLoss of information

Solution Approach 1:

The patent segments the microbiome analysis into hierarchical levels: first organizing genes into functional pathways, then grouping pathways into metabolic modules, and finally aggregating modules into guild-level functional units. This segmentation strategy maintains ecological interaction information at each hierarchical level while enabling efficient database annotation and analysis at the consolidated guild level

Inventive Principle:
Principle #1Segmentation

3Device complexity

If competing bacterial strains encode the same functional gene, then gene annotation is simplified, but opposite growth trajectories are masked leading to neutralized signals

Engineering Contradiction:
Improvesimplicity of gene annotationVSAvoidprecision of functional contribution measurement
Core Design Contradiction:
Device complexityVSMeasurement precision

Solution Approach 1:

The patent applies local quality analysis by examining the specific ecological context and growth trajectory of each bacterial strain carrying a functional gene. Instead of uniformly annotating all copies of a gene, the method assigns different weights or signs to gene copies based on their carrier strains' ecological roles and growth patterns, thereby preserving opposite changes from competing strains while maintaining annotation efficiency

Inventive Principle:
Principle #3Local quality

Data Source

PatentUS20250285756A1Two competing guilds as core microbiome signature for human diseases
Publication Date: 2025.09.11 RUTGERS THE STATE UNIV
  • US20250285756A1 patent drawing
  • US20250285756A1 patent drawing
  • US20250285756A1 patent drawing

AI summary

Methods and systems for determining a disease state by obtaining a first plurality of nucleic acid sequences for genomic DNA from a sample from the gut of a subject. Determine, from the nucleic acid sequences a first plurality of genomic abundance values for a first plurality of gut bacteria and a second plurality of genomic abundance values for a second plurality of at least 20 species of gut bacteria. Apply a model to at least the first plurality of genomic abundance values and the second plurality of genomic abundance values, or one or more combinations thereof, thereby determining the disease state of the subject as an output of the model.